Contact Information

37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG

We Are Available 24/ 7. Call Now.
Microsoft Shows AI Won't Be a Loss Leader
Finances

Microsoft Shows AI Won't Be a Loss Leader

The software company’s pricing of its Copilot AI tool came in well above projections. Source link

Meta, Microsoft Team Up to Offer New AI Software for Businesses
Business

Meta, Microsoft Team Up to Offer New AI Software for Businesses

The Meta AI model, dubbed Llama 2, will be free and available to developers building software on Microsoft’s Azure cloud-computing platform. Source link

Tesla Outlines Plan to Create Largest Auto Factory in Germany
Business

Tesla Outlines Plan to Create Largest Auto Factory in Germany

Electric-vehicle maker aims to double capacity of Berlin-area plant to one million cars a year. Source link

FDA Approves First RSV Drug to Protect All Infants
Business

FDA Approves First RSV Drug to Protect All Infants

While the virus often leads to mild, coldlike symptoms, it is the leading cause of hospitalization of infants in the U.S. Source link

Cathie Wood's ARK Writes Down Twitter Stake by 47%
Finances

Cathie Wood's ARK Writes Down Twitter Stake by 47%

Wood is still bullish on Twitter’s long-term outlook and said her fund updates its internal valuations of private companies frequently. Source link

FDA Approves First Over-the-Counter Birth-Control Pill
Business

FDA Approves First Over-the-Counter Birth-Control Pill

The Food and Drug Administration approved the first over-the-counter birth-control pill, significantly expanding access to contraception among women across the U.S.   Source link

Saudi Arabia to Lose Top Spot in OPEC+
Finances

Saudi Arabia to Lose Top Spot in OPEC+

The kingdom is set to fall below Russia as the largest oil producer in the alliance as its production cuts begin to bite, tightening the

FDA Approval Isn't Always a Happy Day for Biotech Investors
Business

FDA's OK Isn't Always a Happy Day for Biotech Investors

In recent weeks, three closely watched FDA decisions came in positive for the companies—followed by their stocks going negative. Source link